SEQ2FUN

FURNA

Search Ligand

Ligand ID    Formula    InChI    InChIKey    SMILES    Ligand name     

Browse Ligand

  • Click # to view 2D diagram of the ligand.
  • The 3-letter Ligand ID follows the Chemical Component Dictionary (CCD) used by the PDB database. When availble, the Ligand ID from ChEMBL, DrugBank, and ZINC databases are also listed in the form of CHEMBL*, DB*, and ZINC*, respectively. Click on the Ligand ID to view the ligand at RCSB PDB, ChEMBL, DrugBank or ZINC.
  • Count is the number of interactions with the ligand. The full statistics is available at lig_frequency.txt. Click Count to search the ligand through the database.
  • If multiple SMILES strings exists for the same ligand, different SMILES are separated by semicolon ";".

    • Sort by

    << < 1 2 3 4 > >>
    Go to page
    [Click to hide 2D diagrams for ligand structures]
    # ID Count Chemical
    formula     		InChI;
    InChIKey     		SMILES Ligand
    Name
    601
    V71
    ZINC000584905703    		 2 C12 H25 F N4 O5 InChI=1S/C12H25FN4O5/c13-
    6-5(2-14)21-12(7(17)9(6)1
    9)22-11-4(16)1-3(15)8(18)
    10(11)20/h3-12,18-20H,1-2
    ,14-17H2/t3-,4+,5-,6+,7-,
    8+,9+,10-,11-,12-/m1/s1;
    CRXNRBKQEXVRGM-RMDUJVAESA-N    		 NC[CH]1O[CH](O[CH]2[CH](N)C[CH](N)[CH](O
    )[CH]2O)[CH](N)[CH](O)[CH]1F; NC[C@H]1O[
    C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)
    [C@H]2O)[C@H](N)[C@@H](O)[C@H]1F; C1C(C(
    C(C(C1N)OC2C(C(C(C(O2)CN)F)O)N)O)O)N; C1
    [C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H
    ]2[C@@H]([C@H]([C@H]([C@H](O2)CN)F)O)N)O
    )O)N; C1(C(C(O)C(C(CN)O1)F)N)OC2C(C(O)C(
    N)CC2N)O    		 (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,4,6-trideoxy-4-fluoro-alpha-D-galactopyranoside;
    (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,4,6-trideoxy-4-fluoro-alpha-D-galactoside;
    (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,4,6-trideoxy-4-fluoro-D-galactoside;
    (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,4,6-trideoxy-4-fluoro-galactoside
    602
    V7A
    CHEMBL2364632
    DB12035
    ZINC000072319783    		 8 C24 H29 N3 O8 InChI=1S/C24H29N3O8/c1-26
    (2)18-13-8-11-7-12-10(9-2
    7(3)35-4)5-6-14(28)16(12)
    19(29)15(11)21(31)24(13,3
    4)22(32)17(20(18)30)23(25
    )33/h5-6,11,13,18,28,30-3
    1,34H,7-9H2,1-4H3,(H2,25,
    33)/t11-,13-,18-,24-/m0/s
    1;
    PQJQFLNBMSCUSH-SBAJWEJLSA-N    		 CN(C)C1C2CC3Cc4c(ccc(c4C(=O)C3=C(C2(C(=O
    )C(=C1O)C(=O)N)O)O)O)CN(C)OC; CON(C)Cc1c
    cc(O)c2C(=O)C3=C(O)[C]4(O)[CH](C[CH]3Cc1
    2)[CH](N(C)C)C(=C(C(N)=O)C4=O)O; c1(ccc(
    O)c2c1CC3C(C2=O)=C(O)C4(C(C3)C(C(=C(C4=O
    )C(N)=O)O)N(C)C)O)CN(C)OC; CN(C)[C@H]1[C
    @@H]2C[C@@H]3Cc4c(ccc(c4C(=O)C3=C([C@@]2
    (C(=O)C(=C1O)C(=O)N)O)O)O)CN(C)OC; CON(C
    )Cc1ccc(O)c2C(=O)C3=C(O)[C@@]4(O)[C@@H](
    C[C@@H]3Cc12)[C@H](N(C)C)C(=C(C(N)=O)C4=
    O)O    		 Sarecycline
    603
    V8A
    CHEMBL257142
    ZINC000095607768    		 4 C42 H60 N8 O8 InChI=1S/C42H60N8O8/c51-3
    9-31-29-33(43-5-1-7-45-13
    -21-55-22-14-45)37-35-32(
    40(52)49(41(37)53)11-3-9-
    47-17-25-57-26-18-47)30-3
    4(44-6-2-8-46-15-23-56-24
    -16-46)38(36(31)35)42(54)
    50(39)12-4-10-48-19-27-58
    -28-20-48/h29-30,43-44H,1
    -28H2;
    PBXBULWQEKJFOX-UHFFFAOYSA-N    		 c1c2c3c4c(cc(c3C(=O)N(C2=O)CCCN5CCOCC5)N
    CCCN6CCOCC6)C(=O)N(C(=O)c4c1NCCCN7CCOCC7
    )CCCN8CCOCC8; O=C1N(CCCN2CCOCC2)C(=O)c3c
    (NCCCN4CCOCC4)cc5C(=O)N(CCCN6CCOCC6)C(=O
    )c7c(NCCCN8CCOCC8)cc1c3c57; C(CCN1CCOCC1
    )N2C(=O)c7c6c(C2=O)cc(NCCCN3CCOCC3)c5C(=
    O)N(CCCN4CCOCC4)C(c(c56)cc7NCCCN8CCOCC8)
    =O    		 2,7-bis[3-(morpholin-4-yl)propyl]-4,9-bis{[3-(morpholin-4-yl)propyl]amino}benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone
    604
    V8C    		 3 C25 H23 N3 O4 InChI=1S/C25H23N3O4/c1-27
    (2)15-6-9-18-21(12-15)32-
    22-13-16(28(3)4)7-10-19(2
    2)23(18)17-8-5-14(24(26)2
    9)11-20(17)25(30)31/h5-13
    H,1-4H3,(H2-,26,29,30,31);
    TZKHAYIVKGBSEZ-UHFFFAOYSA-N    		 CN(C)c1ccc2c(OC3=CC(C=CC3=C2c4ccc(cc4C([
    O-])=O)C(N)=O)=[N+](C)C)c1; CN(C)c1ccc2c
    (c1)OC3=CC(=[N+](C)C)C=CC3=C2c4ccc(cc4C(
    =O)[O-])C(=O)N    		 5-aminocarbonyl-2-[3-(dimethylamino)-6-dimethylazaniumylidene-xanthen-9-yl]benzoate
    605
    VAL
    CHEMBL43068
    DB00161
    ZINC000000895099    		 10 C5 H11 N O2 InChI=1S/C5H11NO2/c1-3(2)
    4(6)5(7)8/h3-4H,6H2,1-2H3
    ,(H,7,8)/t4-/m0/s1;
    KZSNJWFQEVHDMF-BYPYZUCNSA-N    		 O=C(O)C(N)C(C)C; CC(C)C(C(=O)O)N; CC(C)[
    C@@H](C(=O)O)N; CC(C)[C@H](N)C(O)=O; CC(
    C)[CH](N)C(O)=O    		 VALINE
    606
    VDU    		 2 C20 H30 F N O4 InChI=1S/C20H30FNO4/c1-10
    -13(6-15(24)12-5-17(25)22
    -18(12)26)20(4)9-11(21)8-
    19(2,3)16(20)7-14(10)23/h
    11-16,23-24H,1,5-9H2,2-4H
    3,(H,22,25,26)/t11-,12+,1
    3-,14-,15-,16-,20+/m0/s1;
    GYMIYUOGANGZND-LWHFJPTFSA-N    		 CC1(CC(CC2(C1CC(C(=C)C2CC(C3CC(=O)NC3=O)
    O)O)C)F)C; CC1(C)C[CH](F)C[C]2(C)[CH](C[
    CH](O)[CH]3CC(=O)NC3=O)C(=C)[CH](O)C[CH]
    12; CC1(C)C[C@H](F)C[C@]2(C)[C@@H](C[C@H
    ](O)[C@H]3CC(=O)NC3=O)C(=C)[C@@H](O)C[C@
    @H]12; C[C@]12C[C@H](CC([C@@H]1C[C@@H](C
    (=C)[C@@H]2C[C@@H]([C@H]3CC(=O)NC3=O)O)O
    )(C)C)F    		 fluorolissoclimide;
    (3R)-3-[(1S)-2-[(1R,3S,4aS,7S,8aS)-7-fluoranyl-5,5,8a-trimethyl-2-methylidene-3-oxidanyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione
    607
    VIB
    CHEMBL1547
    DB00152
    ZINC000000049153    		 2 C12 H17 N4 O S InChI=1S/C12H17N4OS/c1-8-
    11(3-4-17)18-7-16(8)6-10-
    5-14-9(2)15-12(10)13/h5,7
    ,17H,3-4,6H2,1-2H3,(H2,13
    ,14,15)/q+1;
    JZRWCGZRTZMZEH-UHFFFAOYSA-N    		 n1c(c(cnc1C)C[n+]2c(c(sc2)CCO)C)N; Cc1nc
    c(C[n+]2csc(CCO)c2C)c(N)n1; Cc1c(sc[n+]1
    Cc2cnc(nc2N)C)CCO    		 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM;
    THIAMIN;
    VITAMIN B1
    608
    VIF
    CHEMBL4455473    		 4 C28 H38 F N3 O6 InChI=1S/C28H38FN3O6/c1-1
    7(2)26-19(4)9-10-24(34)30
    -11-5-7-18(3)13-21(33)14-
    20(29)15-25-31-22(16-37-2
    5)27(35)32-12-6-8-23(32)2
    8(36)38-26/h5,7,9-10,13,1
    6-17,19-21,23,26,33H,6,8,
    11-12,14-15H2,1-4H3,(H,30
    ,34)/b7-5+,10-9+,18-13+/t
    19-,20-,21-,23-,26-/m1/s1;
    DFSJQGCLWZVMOD-IQIMCDJDSA-N    		 CC(C)[C@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(C
    [C@H](F)C[C@H](O)/C=C(C)/C=C/CNC(=O)\C=C
    \[C@H]1C)n3; O=C2N1CCCC1C(=O)OC(C(C=CC(=
    O)NCC=CC(=CC(O)CC(F)Cc3nc2co3)C)C)C(C)C;
    CC1C=CC(=O)NCC=CC(=CC(CC(Cc2nc(co2)C(=O
    )N3CCCC3C(=O)OC1C(C)C)F)O)C; C[C@@H]1/C=
    C/C(=O)NC/C=C/C(=C/[C@H](C[C@H](Cc2nc(co
    2)C(=O)N3CCC[C@@H]3C(=O)O[C@@H]1C(C)C)F)
    O)/C; CC(C)[CH]1OC(=O)[CH]2CCCN2C(=O)c3c
    oc(C[CH](F)C[CH](O)C=C(C)C=CCNC(=O)C=C[C
    H]1C)n3    		 Flopristin
    609
    VIR
    CHEMBL1236670
    DB01669    		 5 C28 H35 N3 O7 InChI=1S/C28H35N3O7/c1-17
    (2)26-19(4)9-10-24(34)29-
    11-5-7-18(3)13-20(32)14-2
    1(33)15-25-30-22(16-37-25
    )27(35)31-12-6-8-23(31)28
    (36)38-26/h5,7-10,13,16-1
    7,19-20,26,32H,6,11-12,14
    -15H2,1-4H3,(H,29,34)/b7-
    5+,10-9+,18-13+/t19-,20-,
    26-/m1/s1;
    DAIKHDNSXMZDCU-FQTGFAPKSA-N    		 CC1C=CC(=O)NCC=CC(=CC(CC(=O)Cc2nc(co2)C(
    =O)N3CCC=C3C(=O)OC1C(C)C)O)C; CC(C)[CH]1
    OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[CH](O)C
    =C(C)C=CCNC(=O)C=C[CH]1C)n3; CC(C)[C@H]1
    OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)
    \C=C(C)\C=C\CNC(=O)\C=C\[C@H]1C)n3; C[C@
    @H]1\C=C\C(=O)NC\C=C\C(=C\[C@H](CC(=O)Cc
    2nc(co2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)
    O)\C; O=C2N1C(=CCC1)C(=O)OC(C(C=CC(=O)NC
    C=CC(=CC(O)CC(=O)Cc3nc2co3)C)C)C(C)C    		 VIRGINIAMYCIN M1
    610
    VK0    		 6 C26 H23 N2 O S InChI=1S/C26H23N2OS/c1-27
    -15-14-20(17-26-28(2)24-6
    -4-5-7-25(24)30-26)22-16-
    19(10-13-23(22)27)18-8-11
    -21(29-3)12-9-18/h4-17H,1
    -3H3/q+1;
    STDKZFOWAXBTNR-UHFFFAOYSA-N    		 COc1ccc(cc1)c2ccc3N(C)C=CC(=C\c4sc5ccccc
    5[n+]4C)/c3c2; COc1ccc(cc1)c1ccc2c(c1)C(
    \C=CN2C)=C\c1sc2ccccc2[n+]1C; C[n+]1c2cc
    ccc2sc1/C=C/3\C=CN(c4c3cc(cc4)c5ccc(cc5)
    OC)C; C[n+]1c2ccccc2sc1C=C3C=CN(c4c3cc(c
    c4)c5ccc(cc5)OC)C; COc1ccc(cc1)c2ccc3N(C
    )C=CC(=Cc4sc5ccccc5[n+]4C)c3c2    		 2-[(~{E})-[6-(4-methoxyphenyl)-1-methyl-quinolin-4-ylidene]methyl]-3-methyl-1,3-benzothiazole
    611
    VKI    		 1 C45 H55 N6 O7 S2 InChI=1S/C45H54N6O7S2/c1-
    50-20-17-33(35-27-32(13-1
    6-37(35)50)31-11-14-34(55
    -2)15-12-31)28-43-51(38-7
    -3-4-8-39(38)60-43)29-42(
    53)47-19-22-57-24-26-58-2
    5-23-56-21-18-46-41(52)10
    -6-5-9-40-44-36(30-59-40)
    48-45(54)49-44/h3-4,7-8,1
    1-17,20,27-28,36,40,44H,5
    -6,9-10,18-19,21-26,29-30
    H2,1-2H3,(H3-,46,47,48,49
    ,52,53,54)/p+1;
    WHIFPTXUSZXQNM-UHFFFAOYSA-O    		 COc1ccc(cc1)c2ccc3N(C)C=CC(=C/c4sc5ccccc
    5[n+]4CC(=O)NCCOCCOCCOCCNC(=O)CCCCC6SCC7
    NC(=O)NC67)\c3c2; COc1ccc(cc1)c2ccc3N(C)
    C=CC(=Cc4sc5ccccc5[n+]4CC(=O)NCCOCCOCCOC
    CNC(=O)CCCCC6SCC7NC(=O)NC67)c3c2; CN1C=C
    C(=Cc2[n+](c3ccccc3s2)CC(=O)NCCOCCOCCOCC
    NC(=O)CCCCC4C5C(CS4)NC(=O)N5)c6c1ccc(c6)
    c7ccc(cc7)OC; CN1C=C/C(=C\c2[n+](c3ccccc
    3s2)CC(=O)NCCOCCOCCOCCNC(=O)CCCCC4C5C(CS
    4)NC(=O)N5)/c6c1ccc(c6)c7ccc(cc7)OC; O=C
    1NC2C(CCCCC(=O)NCCOCCOCCOCCNC(=O)C[n+]3c
    4ccccc4sc3/C=C3\C=CN(C)c4ccc(cc43)c3ccc(
    OC)cc3)SCC2N1    		 3-[2,16-dioxo-20-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-6,9,12-trioxa-3,15-diazaicosan-1-yl]-2-{(E)-[6-(4-methoxyphenyl)-1-methylquinolin-4(1H)-ylidene]methyl}-1,3-benzothiazol-3-ium
    612
    VLR    		 3 C45 H55 N6 O7 S2 InChI=1S/C45H54N6O7S2/c1-
    50-20-17-33(35-27-32(13-1
    6-37(35)50)31-11-14-34(55
    -2)15-12-31)28-43-51(38-7
    -3-4-8-39(38)60-43)29-42(
    53)47-19-22-57-24-26-58-2
    5-23-56-21-18-46-41(52)10
    -6-5-9-40-44-36(30-59-40)
    48-45(54)49-44/h3-4,7-8,1
    1-17,20,27-28,36,40,44H,5
    -6,9-10,18-19,21-26,29-30
    H2,1-2H3,(H3-,46,47,48,49
    ,52,53,54)/p+1/t36-,40-,4
    4+/m1/s1;
    WHIFPTXUSZXQNM-FPNRCKICSA-O    		 COc1ccc(cc1)c2ccc3N(C)C=CC(=C/c4sc5ccccc
    5[n+]4CC(=O)NCCOCCOCCOCCNC(=O)CCCC[C@H]6
    SC[C@H]7NC(=O)N[C@H]67)\c3c2; CN1C=CC(=C
    c2[n+](c3ccccc3s2)CC(=O)NCCOCCOCCOCCNC(=
    O)CCCCC4C5C(CS4)NC(=O)N5)c6c1ccc(c6)c7cc
    c(cc7)OC; CN1C=CC(=Cc2[n+](c3ccccc3s2)CC
    (=O)NCCOCCOCCOCCNC(=O)CCCC[C@@H]4[C@@H]5
    [C@@H](CS4)NC(=O)N5)c6c1ccc(c6)c7ccc(cc7
    )OC; O=C1NC2C(CCCCC(=O)NCCOCCOCCOCCNC(=O
    )C[n+]3c4ccccc4sc3/C=C3\C=CN(C)c4ccc(cc4
    3)c3ccc(OC)cc3)SCC2N1; COc1ccc(cc1)c2ccc
    3N(C)C=CC(=Cc4sc5ccccc5[n+]4CC(=O)NCCOCC
    OCCOCCNC(=O)CCCC[CH]6SC[CH]7NC(=O)N[CH]6
    7)c3c2    		 3-{2,16-dioxo-20-[(3aS,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-2-{(E)-[6-(4-methoxyphenyl)-1-methylquinolin-4(1H)-ylidene]methyl}-1,3-benzothiazol-3-ium
    613
    VTE
    CHEMBL5273378    		 4 C22 H22 N2 O6 InChI=1S/C22H22N2O6/c25-1
    6-10-15(11-17(26)21(16)28
    )20(27)19-12-14-9-13(3-4-
    18(14)30-19)22(29)23-5-8-
    24-6-1-2-7-24/h3-4,9-12,2
    5-26,28H,1-2,5-8H2,(H,23,
    29);
    FQUBMOYVKLVEKR-UHFFFAOYSA-N    		 c1cc2c(cc1C(=O)NCCN3CCCC3)cc(o2)C(=O)c4c
    c(c(c(c4)O)O)O; Oc1cc(cc(O)c1O)C(=O)c2oc
    3ccc(cc3c2)C(=O)NCCN4CCCC4    		 ~{N}-(2-pyrrolidin-1-ylethyl)-2-[3,4,5-tris(oxidanyl)phenyl]carbonyl-1-benzofuran-5-carboxamide
    614
    VTR    		 4 C22 H20 Br2 N2 O6 InChI=1S/C22H20Br2N2O6/c2
    3-16-15(17(24)20(29)21(30
    )19(16)28)18(27)14-10-12-
    9-11(3-4-13(12)32-14)22(3
    1)25-5-8-26-6-1-2-7-26/h3
    -4,9-10,28-30H,1-2,5-8H2,
    (H,25,31);
    IZFDDCJWJDARBQ-UHFFFAOYSA-N    		 c1cc2c(cc1C(=O)NCCN3CCCC3)cc(o2)C(=O)c4c
    (c(c(c(c4Br)O)O)O)Br; Oc1c(O)c(Br)c(c(Br
    )c1O)C(=O)c2oc3ccc(cc3c2)C(=O)NCCN4CCCC4    		 2-[2,6-bis(bromanyl)-3,4,5-tris(oxidanyl)phenyl]carbonyl-~{N}-(2-pyrrolidin-1-ylethyl)-1-benzofuran-5-carboxamide
    615
    W6F    		 3 C39 H51 N6 O6 S2 InChI=1S/C39H50N6O6S2/c1-
    27-11-12-29-28(13-16-44(2
    )32(29)23-27)24-37-45(31-
    7-3-4-8-33(31)53-37)25-36
    (47)41-15-18-50-20-22-51-
    21-19-49-17-14-40-35(46)1
    0-6-5-9-34-38-30(26-52-34
    )42-39(48)43-38/h3-4,7-8,
    11-13,16,23-24,30,34,38H,
    5-6,9-10,14-15,17-22,25-2
    6H2,1-2H3,(H3-,40,41,42,4
    3,46,47,48)/p+1/t30-,34-,
    38?/m0/s1;
    OPDJCBUXWAHTAM-PJXAABHXSA-O    		 Cc1ccc2c(c1)N(C=CC2=Cc3[n+](c4ccccc4s3)C
    C(=O)NCCOCCOCCOCCNC(=O)CCCCC5C6C(CS5)NC(
    =O)N6)C; Cc1ccc\2c(c1)N(C=C/C2=C\c3[n+](
    c4ccccc4s3)CC(=O)NCCOCCOCCOCCNC(=O)CCCC[
    C@H]5[C@@H]6[C@H](CS5)NC(=O)N6)C; CN1C=C
    C(=Cc2sc3ccccc3[n+]2CC(=O)NCCOCCOCCOCCNC
    (=O)CCCC[CH]4SC[CH]5NC(=O)N[CH]45)c6ccc(
    C)cc16; O=C1NC2C(CCCCC(=O)NCCOCCOCCOCCNC
    (=O)C[n+]3c4ccccc4sc3/C=C3\C=CN(C)c4cc(C
    )ccc43)SCC2N1; CN1C=CC(=C\c2sc3ccccc3[n+
    ]2CC(=O)NCCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[
    C@@H]5NC(=O)N[C@H]45)/c6ccc(C)cc16    		 2-[(E)-(1,7-dimethylquinolin-4(1H)-ylidene)methyl]-3-{2,16-dioxo-20-[(3aR,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-1,3-benzothiazol-3-ium
    616
    WC9    		 6 C25 H42 N2 O6 S InChI=1S/C25H42N2O6S/c1-1
    3(2)10-15-7-8-32-22-16(11
    -15)12-26-18(22)24(31)27-
    17-14(3)6-4-5-9-34-25-21(
    30)19(28)20(29)23(17)33-2
    5/h4,6,13-23,25-26,28-30H
    ,5,7-12H2,1-3H3,(H,27,31)
    /b6-4-/t14-,15+,16+,17-,1
    8+,19+,20-,21-,22-,23-,25
    -/m1/s1;
    GMONVEGLHZWYNO-JBYNEVPESA-N    		 CC(C)C[CH]1CCO[CH]2[CH](CN[CH]2C(=O)N[CH
    ]3[CH](C)C=CCCS[CH]4O[CH]3[CH](O)[CH](O)
    [CH]4O)C1; CC1C=CCCSC2C(C(C(C(C1NC(=O)C3
    C4C(CC(CCO4)CC(C)C)CN3)O2)O)O)O; CC(C)C[
    C@@H]1CCO[C@@H]2[C@H](CN[C@@H]2C(=O)N[C@
    @H]3[C@H](C)\C=C/CCS[C@H]4O[C@H]3[C@H](O
    )[C@H](O)[C@H]4O)C1; C[C@@H]1/C=C\CCS[C@
    @H]2[C@@H]([C@H]([C@H]([C@@H]([C@@H]1NC(
    =O)[C@@H]3[C@H]4[C@@H](C[C@@H](CCO4)CC(C
    )C)CN3)O2)O)O)O; CC(C)CC1CC2CNC(C2OCC1)C
    (=O)NC1C2OC(SCCC=CC1C)C(O)C(O)C2O    		 (4S,5aS,8S,8aR)-4-(2-methylpropyl)-N-[(1R,5Z,7R,8R,9R,10R,11S,12R)-10,11,12-trihydroxy-7-methyl-13-oxa-2-thiabicyclo[7.3.1]tridec-5-en-8-yl]octahydro-2H-oxepino[2,3-c]pyrrole-8-carboxamide (non-preferred name)
    617
    WCP    		 2 C26 H26 F N5 O5 InChI=1S/C26H26FN5O5/c27-
    16-10-28-17-2-4-20(34)32-
    13-26(35,21(16)22(17)32)1
    2-25-7-5-24(6-8-25,14-37-
    25)29-9-15-1-3-18-23(30-1
    5)31-19(33)11-36-18/h1-4,
    10,29,35H,5-9,11-14H2,(H,
    30,31,33)/t24-,25-,26-/m0
    /s1;
    XTHQMKOHGLBSON-GSDHBNRESA-N    		 c1cc2c(nc1CNC34CCC(CC3)(OC4)C[C@@]5(CN6c
    7c5c(cnc7C=CC6=O)F)O)NC(=O)CO2; O[C@]1(C
    N2C(=O)C=Cc3ncc(F)c1c23)CC45CCC(CC4)(CO5
    )NCc6ccc7OCC(=O)Nc7n6; O=C5C=Cc7ncc(c6C(
    O)(CC21OCC(CC1)(CC2)NCc4nc3NC(=O)COc3cc4
    )CN5c67)F; c1cc2c(nc1CNC34CCC(CC3)(OC4)C
    C5(CN6c7c5c(cnc7C=CC6=O)F)O)NC(=O)CO2; O
    [C]1(CN2C(=O)C=Cc3ncc(F)c1c23)CC45CCC(CC
    4)(CO5)NCc6ccc7OCC(=O)Nc7n6    		 (4R)-3-fluoro-4-hydroxy-4-{[(1r,4R)-4-{[(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methyl]amino}-2-oxabicyclo[2.2.2]oct-1-yl]methyl}-4,5-dihydro-7H-pyrrolo[3,2,1-de][1,5]naphthyridin-7-one
    618
    WDP    		 2 C61 H102 N4 O20 S InChI=1S/C61H102N4O20S/c1
    -32(2)25-45(66)81-51-39(9
    )50(34(4)30-77-58-54(75-1
    8)53(74-17)47(67)42(12)80
    -58)83-56(70)41(11)52(82-
    46-26-35(5)65(16)29-37(7)
    78-46)38(8)49(84-57-48(68
    )44(64-76-19)27-36(6)79-5
    7)33(3)28-61(15,55(69)40(
    51)10)85-59(71)63-60(13,1
    4)31-62-86(72,73)43-23-21
    -20-22-24-43/h20-24,32-42
    ,46-54,57-58,62,67-68H,25
    -31H2,1-19H3,(H,63,71)/b6
    4-44+/t33-,34-,35+,36+,37
    -,38+,39-,40+,41+,42+,46-
    ,47+,48+,49-,50+,51+,52-,
    53+,54+,57-,58+,61-/m0/s1;
    IXJRUHKGLMWLLP-XMRFQGNKSA-N    		 CON=C1C[CH](C)O[CH](O[CH]2[CH](C)C[C](C)
    (OC(=O)NC(C)(C)CN[S](=O)(=O)c3ccccc3)C(=
    O)[CH](C)[CH](OC(=O)CC(C)C)[CH](C)[CH](O
    C(=O)[CH](C)[CH](O[CH]4C[CH](C)N(C)C[CH]
    (C)O4)[CH]2C)[CH](C)CO[CH]5O[CH](C)[CH](
    O)[CH](OC)[CH]5OC)[CH]1O; CO\N=C1/C[C@@H
    ](C)O[C@@H](O[C@H]2[C@@H](C)C[C@](C)(OC(
    =O)NC(C)(C)CN[S](=O)(=O)c3ccccc3)C(=O)[C
    @H](C)[C@H](OC(=O)CC(C)C)[C@@H](C)[C@H](
    OC(=O)[C@H](C)[C@@H](O[C@H]4C[C@@H](C)N(
    C)C[C@H](C)O4)[C@@H]2C)[C@@H](C)CO[C@@H]
    5O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]5OC)[C
    @@H]1O; CC1CC(OC(CN1C)C)OC2C(C(C(CC(C(=O
    )C(C(C(C(OC(=O)C2C)C(C)COC3C(C(C(C(O3)C)
    O)OC)OC)C)OC(=O)CC(C)C)C)(C)OC(=O)NC(C)(
    C)CNS(=O)(=O)c4ccccc4)C)OC5C(C(=NOC)CC(O
    5)C)O)C; C[C@@H]1C[C@@H](O[C@H](CN1C)C)O
    [C@H]2[C@@H]([C@H]([C@H](C[C@](C(=O)[C@@
    H]([C@@H]([C@H]([C@H](OC(=O)[C@@H]2C)[C@
    @H](C)CO[C@H]3[C@@H]([C@@H]([C@@H]([C@H]
    (O3)C)O)OC)OC)C)OC(=O)CC(C)C)C)(C)OC(=O)
    NC(C)(C)CNS(=O)(=O)c4ccccc4)C)O[C@H]5[C@
    @H](C(=NOC)C[C@H](O5)C)O)C; CC3C(OC1C(C(
    /CC(C)O1)=N/OC)O)C(C(C(C(=O)OC(C(C(C(C(C
    (C)(OC(=O)NC(C)(CNS(c2ccccc2)(=O)=O)C)C3
    )=O)C)OC(=O)CC(C)C)C)C(C)COC4C(C(C(C(C)O
    4)O)OC)OC)C)OC5OC(CN(C(C5)C)C)C)C    		 Sequanamycin 9
    619
    WIN
    CHEMBL509895
    ZINC000030726685    		 1 C28 H36 O11 InChI=1S/C28H36O11/c1-11(
    2)12(3)7-17(30)39-20-22-2
    7-10-37-28(22,25(35)36-6)
    23(33)19(32)21(27)26(5)9-
    15(29)18(31)13(4)14(26)8-
    16(27)38-24(20)34/h7,11,1
    4,16,19-23,31-33H,8-10H2,
    1-6H3/b12-7+/t14-,16+,19+
    ,20+,21+,22+,23-,26-,27+,
    28-/m0/s1;
    IRQXZTBHNKVIRL-GOTQHHPNSA-N    		 COC(=O)[C]12OC[C]34[CH](C[CH]5C(=C(O)C(=
    O)C[C]5(C)[CH]3[CH](O)[CH]1O)C)OC(=O)[CH
    ](OC(=O)C=C(C)C(C)C)[CH]24; CC1=C(C(=O)C
    C2(C1CC3C45C2C(C(C(C4C(C(=O)O3)OC(=O)C=C
    (C)C(C)C)(OC5)C(=O)OC)O)O)C)O; COC(=O)[C
    @@]12OC[C@@]34[C@@H](C[C@H]5C(=C(O)C(=O)
    C[C@]5(C)[C@H]3[C@@H](O)[C@@H]1O)C)OC(=O
    )[C@H](OC(=O)\C=C(C)\C(C)C)[C@@H]24; O=C
    (OC)C15OCC24C1C(OC(=O)\C=C(/C)C(C)C)C(=O
    )OC2CC3C(=C(O)C(=O)CC3(C)C4C(O)C5O)C; CC
    1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@
    H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O
    3)OC(=O)/C=C(\C)/C(C)C)(OC5)C(=O)OC)O)O)
    C)O    		 methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate;
    Bruceantin;
    Picras-3-en-21-oic acid;
    (11beta,12alpha,15beta)-15-[(3,4-Dimethyl-1-oxo-2-pentenyl)oxy]-13,20-epoxy-3,11,12-trihydroxy-2,16-dioxopicras-3-en-21-oic acid methyl ester
    620
    WV3    		 1 C15 H23 N O4 InChI=1S/C15H23NO4/c1-8-3
    -9(2)15(20)11(4-8)12(17)5
    -10-6-13(18)16-14(19)7-10
    /h8-12,17H,3-7H2,1-2H3,(H
    ,16,18,19);
    YPHMISFOHDHNIV-UHFFFAOYSA-N    		 C[C@@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)
    CC2CC(=O)NC(=O)C2; O=C1CC(CC(O)C2CC(C)CC
    (C)C2=O)CC(=O)N1; C[C@@H]1C[C@@H](C(=O)[
    C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C; C
    C1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C;
    C[CH]1C[CH](C)C(=O)[CH](C1)[CH](O)CC2CC(
    =O)NC(=O)C2    		 4-{(2R)-2-[(1R,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione
    621
    WZW    		 4 C23 H30 N13 O13 P2 InChI=1S/C23H30N13O13P2/c
    24-16-10-17(28-5-27-16)33
    (6-29-10)20-14(39)12(37)8
    (48-20)3-46-50(42,43)35-1
    -2-36(23(35)26)51(44,45)4
    7-4-9-13(38)15(40)21(49-9
    )34-7-30-11-18(34)31-22(2
    5)32-19(11)41/h1-2,5-9,12
    -15,20-21,37-40H,3-4,26H2
    ,(H,42,43)(H,44,45)(H2,24
    ,27,28)(H3,25,31,32,41)/t
    8-,9-,12-,13-,14-,15-,20-
    ,21-/m1/s1;
    UTMQQHPBLGAUQK-NAGRZYTCSA-N    		 c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)([N]
    4=C(N(C=C4)P(=O)(O)OCC5C(C(C(O5)n6cnc7c6
    N=C(NC7=O)N)O)O)N)O)O)O)N; c1nc(c2c(n1)n
    (cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O
    )([N]4=C(N(C=C4)P(=O)(O)OC[C@@H]5[C@H]([
    C@H]([C@@H](O5)n6cnc7c6N=C(NC7=O)N)O)O)N
    )O)O)O)N; NC1=Nc2n(cnc2C(=O)N1)[CH]3O[CH
    ](CO[P](O)(=O)n4cc[n](c4N)[P](O)(=O)OC[C
    H]5O[CH]([CH](O)[CH]5O)n6cnc7c(N)ncnc67)
    [CH](O)[CH]3O; NC1=Nc2n(cnc2C(=O)N1)[C@@
    H]3O[C@H](CO[P](O)(=O)n4cc[n](c4N)[P](O)
    (=O)OC[C@H]5O[C@H]([C@H](O)[C@@H]5O)n6cn
    c7c(N)ncnc67)[C@@H](O)[C@H]3O    		 [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-[2-azanyl-3-[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]imidazol-1-yl]phosphinic acid
    622
    X1K
    ZINC000166794629    		 2 C20 H31 N O4 InChI=1S/C20H31NO4/c1-11-
    13(9-15(23)12-8-17(24)21-
    18(12)25)20(4)7-5-6-19(2,
    3)16(20)10-14(11)22/h12-1
    6,22-23H,1,5-10H2,2-4H3,(
    H,21,24,25)/t12-,13+,14+,
    15+,16+,20-/m1/s1;
    PPQGMYUYEYHPEL-ZVZFHZCBSA-N    		 CC1(CCCC2(C1CC(C(=C)C2CC(C3CC(=O)NC3=O)O
    )O)C)C; CC1(C)CCC[C]2(C)[CH](C[CH](O)[CH
    ]3CC(=O)NC3=O)C(=C)[CH](O)C[CH]12; CC1(C
    )CCC[C@]2(C)[C@@H](C[C@H](O)[C@H]3CC(=O)
    NC3=O)C(=C)[C@@H](O)C[C@@H]12; C[C@]12CC
    CC([C@@H]1C[C@@H](C(=C)[C@@H]2C[C@@H]([C
    @H]3CC(=O)NC3=O)O)O)(C)C    		 (3~{R})-3-[(1~{S})-2-[(1~{R},3~{S},4~{a}~{S},8~{a}~{S})-5,5,8~{a}-trimethyl-2-methylidene-3-oxidanyl-3,4,4~{a},6,7,8-hexahydro-1~{H}-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione
    623
    X5R    		 2 C15 H12 F2 N2 O4 InChI=1S/C15H12F2N2O4/c1-
    19-12(3-4-13(20)23-2)18-1
    1(15(19)22)7-8-5-9(16)14(
    21)10(17)6-8/h3-7,21H,1-2
    H3/b4-3+,11-7-;
    LXQQJPJEYBZZSO-ZDVGJPJSSA-N    		 CN1C(=N/C(=C\c2cc(c(c(c2)F)O)F)/C1=O)/C=
    C/C(=O)OC; O=C1C(=C\c2cc(F)c(O)c(F)c2)\N
    =C(/C=C/C(=O)OC)N1C; COC(=O)\C=C\C1=NC(=
    C\c2cc(F)c(O)c(F)c2)/C(=O)N1C; COC(=O)C=
    CC1=NC(=Cc2cc(F)c(O)c(F)c2)C(=O)N1C; CN1
    C(=NC(=Cc2cc(c(c(c2)F)O)F)C1=O)C=CC(=O)O
    C    		 methyl (2E)-3-{(4Z)-4-[(3,5-difluoro-4-hydroxyphenyl)methylidene]-1-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl}prop-2-enoate
    624
    XAN
    CHEMBL1424
    DB02134
    ZINC000013517187    		 11 C5 H4 N4 O2 InChI=1S/C5H4N4O2/c10-4-2
    -3(7-1-6-2)8-5(11)9-4/h1H
    ,(H3,6,7,8,9,10,11);
    LRFVTYWOQMYALW-UHFFFAOYSA-N    		 O=C1NC(=O)c2nc[nH]c2N1; c1[nH]c2c(n1)C(=
    O)NC(=O)N2; O=C2c1ncnc1NC(=O)N2    		 XANTHINE
    625
    XBI    		 2 C21 H33 N O4 InChI=1S/C21H33NO4/c1-11-
    9-20(3,4)17-8-15(23)12(2)
    14(21(17,5)10-11)7-16(24)
    13-6-18(25)22-19(13)26/h1
    1,13-17,23-24H,2,6-10H2,1
    ,3-5H3,(H,22,25,26)/t11-,
    13+,14-,15-,16-,17-,21+/m
    0/s1;
    QJMIOMDKNQXZMN-LYGYNGHHSA-N    		 C[C@@H]1C[C@]2([C@@H](C[C@@H](C(=C)[C@@H
    ]2C[C@@H]([C@H]3CC(=O)NC3=O)O)O)C(C1)(C)
    C)C; CC1CC(C2CC(C(=C)C(C2(C1)C)CC(C3CC(=
    O)NC3=O)O)O)(C)C; C[C@H]1CC(C)(C)[C@@H]2
    C[C@H](O)C(=C)[C@H](C[C@H](O)[C@H]3CC(=O
    )NC3=O)[C@@]2(C)C1; C[CH]1CC(C)(C)[CH]2C
    [CH](O)C(=C)[CH](C[CH](O)[CH]3CC(=O)NC3=
    O)[C]2(C)C1    		 (3~{R})-3-[(1~{S})-2-[(1~{R},3~{S},4~{a}~{S},7~{S},8~{a}~{S})-5,5,7,8~{a}-tetramethyl-2-methylidene-3-oxidanyl-3,4,4~{a},6,7,8-hexahydro-1~{H}-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione
    626
    XXX
    CHEMBL427409
    DB04808
    ZINC000004095654    		 8 C12 H26 N4 O6 InChI=1S/C12H26N4O6/c13-2
    -5-8(18)9(19)6(16)12(21-5
    )22-11-4(15)1-3(14)7(17)1
    0(11)20/h3-12,17-20H,1-2,
    13-16H2/t3-,4+,5-,6-,7+,8
    -,9-,10-,11-,12-/m1/s1;
    SYJXFKPQNSDJLI-HKEUSBCWSA-N    		 NC[CH]1O[CH](O[CH]2[CH](N)C[CH](N)[CH](O
    )[CH]2O)[CH](N)[CH](O)[CH]1O; C1C(C(C(C(
    C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N; NC[C@H
    ]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H
    ](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O; O
    (C1C(O)C(O)C(N)CC1N)C2OC(C(O)C(O)C2N)CN;
    C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C
    @@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O
    )N)O)O)N    		 (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside;
    (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)-TETRAHYDRO-2H-PYRA N-3,4-DIOL;
    NEOMYCIN A;
    NEAMINE;
    (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucoside;
    (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-D-glucoside;
    (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-glucoside
    627
    Y53
    CHEMBL4290141
    DB14918
    ZINC000146605125    		 2 C22 H27 N5 O2 InChI=1S/C22H27N5O2/c1-21
    (2)10-16(11-22(3,4)27-21)
    29-20-8-7-18(25-26-20)17-
    6-5-14(9-19(17)28)15-12-2
    3-24-13-15/h5-9,12-13,16,
    27-28H,10-11H2,1-4H3,(H,2
    3,24);
    STWTUEAWRAIWJG-UHFFFAOYSA-N    		 CC1(CC(CC(N1)(C)C)Oc2ccc(nn2)c3ccc(cc3O)
    c4c[nH]nc4)C; CC1(C)CC(CC(C)(C)N1)Oc2ccc
    (nn2)c3ccc(cc3O)c4c[nH]nc4    		 Branaplam;
    5-(1~{H}-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol
    628
    Y59    		 2 C22 H24 N7 O InChI=1S/C22H24N7O/c1-14-
    9-18(26-29-11-15(2)24-21(
    14)29)17-10-20(30)28-12-1
    6(3-4-19(28)25-17)27-8-7-
    23-22(13-27)5-6-22/h3-4,9
    -12,23H,5-8,13H2,1-2H3,(H
    ,25,30);
    WUBACWPUEMOWBL-UHFFFAOYSA-N    		 Cc1cc(nn2c1nc(c2)C)C3=CC(=O)[N]4=C(N3)C=
    CC(=C4)N5CCNC6(C5)CC6; Cc1cn2nc(cc(C)c2n
    1)C3=CC(=O)[n]4cc(ccc4N3)N5CCNC6(CC6)C5    		 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-1~{H}-pyrido[1,2-a]pyrimidin-4-one
    629
    Y7K    		 2 C22 H41 N3 O8 InChI=1S/C22H41N3O8/c1-12
    -10-21(28,11-25-7-4-13-5-
    8-30-9-6-13)22(29)20(31-1
    2)32-19-17(27)14(23-2)16(
    26)15(24-3)18(19)33-22/h1
    2-20,23-29H,4-11H2,1-3H3/
    t12-,14-,15+,16+,17+,18-,
    19-,20+,21-,22-/m1/s1;
    LKCDGONKFJKONL-WUYRLSBSSA-N    		 C[C@@H]1C[C@]([C@]2([C@@H](O1)O[C@@H]3[C
    @H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)N
    C)O)O)(CNCCC4CCOCC4)O; CN[C@@H]1[C@H](O)
    [C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)
    C[C@@]3(O)CNCCC4CCOCC4)O[C@@H]2[C@H]1O;
    CN[CH]1[CH](O)[CH](NC)[CH]2O[C]3(O)[CH](
    O[CH](C)C[C]3(O)CNCCC4CCOCC4)O[CH]2[CH]1
    O; CC1OC2OC3C(OC2(O)C(O)(CNCCC2CCOCC2)C1
    )C(NC)C(O)C(NC)C3O; CC1CC(C2(C(O1)OC3C(C
    (C(C(C3O2)NC)O)NC)O)O)(CNCCC4CCOCC4)O    		 (2R,4R,4aS,5aR,6S,7S,8R,9S,9aR,10aS)-2-methyl-6,8-bis(methylamino)-4-({[2-(oxan-4-yl)ethyl]amino}methyl)octahydro-2H-pyrano[2,3-b][1,4]benzodioxine-4,4a,7,9(10aH)-tetrol
    630
    YAT
    CHEMBL50588
    DB13393
    ZINC000003830747    		 3 C29 H40 N2 O4 InChI=1S/C29H40N2O4/c1-6-
    18-17-31-10-8-20-14-27(33
    -3)29(35-5)16-23(20)25(31
    )12-21(18)11-24-22-15-28(
    34-4)26(32-2)13-19(22)7-9
    -30-24/h13-16,18,21,24-25
    ,30H,6-12,17H2,1-5H3/t18-
    ,21-,24+,25-/m0/s1;
    AUVVAXYIELKVAI-CKBKHPSWSA-N    		 CC[C@H]1CN2CCc3cc(c(cc3[C@@H]2C[C@@H]1C[
    C@@H]4c5cc(c(cc5CCN4)OC)OC)OC)OC; CC[C@H
    ]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[
    C@H]4NCCc5cc(OC)c(OC)cc45; CCC1CN2CCc3cc
    (c(cc3C2CC1CC4c5cc(c(cc5CCN4)OC)OC)OC)OC
    ; CC[CH]1CN2CCc3cc(OC)c(OC)cc3[CH]2C[CH]
    1C[CH]4NCCc5cc(OC)c(OC)cc45; COc1cc2CCNC
    (CC3CC4c5cc(OC)c(OC)cc5CCN4CC3CC)c2cc1OC    		 emetine;
    (2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
    631
    YB3    		 2 C21 H21 F N6 InChI=1S/C21H21FN6/c1-14-
    12-28-13-16(10-18(22)21(2
    8)24-14)20-23-11-15-9-17(
    3-4-19(15)25-20)27-7-5-26
    (2)6-8-27/h3-4,9-13H,5-8H
    2,1-2H3;
    BAUHPLMKUXWNJQ-UHFFFAOYSA-N    		 CN1CCN(CC1)c2ccc3nc(ncc3c2)c4cn5cc(C)nc5
    c(F)c4; Cc1cn2cc(cc(c2n1)F)c3ncc4cc(ccc4
    n3)N5CCN(CC5)C    		 2-(8-fluoranyl-2-methyl-imidazo[1,2-a]pyridin-6-yl)-6-(4-methylpiperazin-1-yl)quinazoline
    632
    YMZ
    CHEMBL411329
    DB05636
    ZINC000000897089    		 3 C17 H16 F6 N2 O InChI=1S/C17H16F6N2O/c18-
    16(19,20)11-5-3-4-9-10(15
    (26)12-6-1-2-7-24-12)8-13
    (17(21,22)23)25-14(9)11/h
    3-5,8,12,15,24,26H,1-2,6-
    7H2/t12-,15+/m0/s1;
    XEEQGYMUWCZPDN-SWLSCSKDSA-N    		 c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)C(C3
    CCCCN3)O; c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F
    )(F)F)[C@H]([C@@H]3CCCCN3)O; O[CH]([CH]1
    CCCCN1)c2cc(nc3c2cccc3C(F)(F)F)C(F)(F)F;
    O[C@@H]([C@@H]1CCCCN1)c2cc(nc3c2cccc3C(
    F)(F)F)C(F)(F)F    		 (11R,12S)- Mefloquine
    633
    YO3    		 2 C21 H19 N2 O InChI=1S/C21H19N2O/c1-22-
    15-14-16(17-9-3-4-10-18(1
    7)22)8-7-13-21-23(2)19-11
    -5-6-12-20(19)24-21/h3-15
    H,1-2H3/q+1;
    VHMUTYCKXYROKA-UHFFFAOYSA-N    		 C[n+]1c2ccccc2oc1C=CC=C3C=CN(c4c3cccc4)C
    ; CN1C=C\C(=C/C=C/c2oc3ccccc3[n+]2C)c4cc
    ccc14; C[n+]1c2ccccc2oc1/C=C/C=C/3\C=CN(
    c4c3cccc4)C; CN1C=CC(=CC=Cc2oc3ccccc3[n+
    ]2C)c4ccccc14; CN2C=CC(c1c2cccc1)=[C@H][
    C@H]=[C@H]c3[n+](c4c(o3)cccc4)C    		 YO3-biotin;
    3-methyl-2-[(1E,3E)-3-(1-methylquinolin-4(1H)-ylidene)prop-1-en-1-yl]-1,3-benzoxazol-3-ium
    634
    YQM
    CHEMBL4597183
    ZINC000200151468    		 10 C27 H31 F N4 O8 InChI=1S/C27H31FN4O8/c1-3
    1(2)20-13-8-11-7-12-14(28
    )9-15(30-16(33)10-32-5-3-
    4-6-32)21(34)18(12)22(35)
    17(11)24(37)27(13,40)25(3
    8)19(23(20)36)26(29)39/h9
    ,11,13,20,34-35,38,40H,3-
    8,10H2,1-2H3,(H2,29,39)(H
    ,30,33)/t11-,13-,20-,27-/
    m0/s1;
    AKLMFDDQCHURPW-ISIOAQNYSA-N    		 CN(C)[CH]1[CH]2C[CH]3Cc4c(F)cc(NC(=O)CN5
    CCCC5)c(O)c4C(=C3C(=O)[C]2(O)C(=C(C(N)=O
    )C1=O)O)O; O=C(Nc1cc(F)c2CC3CC4C(N(C)C)C
    (=O)C(C(N)=O)=C(O)C4(O)C(=O)C3=C(O)c2c1O
    )CN1CCCC1; CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4
    c(F)cc(NC(=O)CN5CCCC5)c(O)c4C(=C3C(=O)[C
    @]2(O)C(=C(C(N)=O)C1=O)O)O; CN(C)[C@H]1[
    C@@H]2C[C@@H]3Cc4c(cc(c(c4C(=C3C(=O)[C@@
    ]2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCC
    C5)F; CN(C)C1C2CC3Cc4c(cc(c(c4C(=C3C(=O)
    C2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCC
    C5)F    		 Eravacycline
    635
    YRW
    ZINC000030678199    		 1 C6 H7 N3 O InChI=1S/C6H7N3O/c7-5-3-9
    -2-1-4(5)6(8)10/h1-3H,7H2
    ,(H2,8,10);
    MRZUGOPPUMNHGA-UHFFFAOYSA-N    		 c1cncc(c1C(=O)N)N; NC(=O)c1ccncc1N; O=C(
    N)c1ccncc1N    		 3-aminopyridine-4-carboxamide
    636
    YXM    		 2 C32 H35 N2 O5 P InChI=1S/C32H35N2O5P/c35-
    24-30(32(37)25-19-21-26(2
    2-20-25)34(38)39)33-31(36
    )18-10-11-23-40(27-12-4-1
    -5-13-27,28-14-6-2-7-15-2
    8)29-16-8-3-9-17-29/h1-9,
    12-17,19-22,30,32,35,37,4
    0H,10-11,18,23-24H2,(H,33
    ,36)/t30-,32-/m1/s1;
    QTBIPHCDEMVXOU-XLJNKUFUSA-N    		 OC[CH](NC(=O)CCCC[PH](c1ccccc1)(c2ccccc2
    )c3ccccc3)[CH](O)c4ccc(cc4)[N+]([O-])=O;
    c1ccc(cc1)P(CCCCC(=O)N[C@H](CO)[C@@H](c
    2ccc(cc2)[N+](=O)[O-])O)(c3ccccc3)c4cccc
    c4; [O-][N+](=O)c1ccc(cc1)C(O)C(CO)NC(=O
    )CCCCP(c1ccccc1)(c1ccccc1)c1ccccc1; c1cc
    c(cc1)P(CCCCC(=O)NC(CO)C(c2ccc(cc2)[N+](
    =O)[O-])O)(c3ccccc3)c4ccccc4; OC[C@@H](N
    C(=O)CCCC[PH](c1ccccc1)(c2ccccc2)c3ccccc
    3)[C@H](O)c4ccc(cc4)[N+]([O-])=O    		 N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-5-(triphenyl-lambda~5~-phosphanyl)pentanamide
    637
    Z2V    		 1 C22 H28 N2 O5 InChI=1S/C22H28N2O5/c1-13
    -11-22(2,24-21(29)15-6-4-
    3-5-7-15)12-16(20(13)28)1
    7(25)8-14-9-18(26)23-19(2
    7)10-14/h3-7,13-14,16-17,
    25H,8-12H2,1-2H3,(H,24,29
    )(H,23,26,27)/t13-,16-,17
    +,22+/m0/s1;
    HNMIURKVBYLOSU-NYGMARBTSA-N    		 CC1CC(CC(C1=O)C(CC2CC(=O)NC(=O)C2)O)(C)N
    C(=O)c3ccccc3; C[C@H]1C[C@@](C[C@H](C1=O
    )[C@@H](CC2CC(=O)NC(=O)C2)O)(C)NC(=O)c3c
    cccc3; C[C@H]1C[C@](C)(C[C@@H]([C@H](O)C
    C2CC(=O)NC(=O)C2)C1=O)NC(=O)c3ccccc3; C[
    CH]1C[C](C)(C[CH]([CH](O)CC2CC(=O)NC(=O)
    C2)C1=O)NC(=O)c3ccccc3; O=C1CC(CC(O)C2CC
    (C)(NC(=O)c3ccccc3)CC(C)C2=O)CC(=O)N1    		 N-[(1R,3S,4R,5S)-3-{(1R)-2-[(2R,4r,6S)-2,6-dihydroxypiperidin-4-yl]-1-hydroxyethyl}-4-hydroxy-1,5-dimethylcyclohexyl]benzamide
    638
    ZAN
    ZINC000034177510    		 2 C10 H17 N6 O12 P3 InChI=1S/C10H17N6O12P3/c1
    1-8-5-9(13-2-12-8)16(3-14
    -5)10-7(18)6(17)4(27-10)1
    -26-29(19,20)15-30(21,22)
    28-31(23,24)25/h2-4,6-7,1
    0,17-18H,1H2,(H2,11,12,13
    )(H2,23,24,25)(H3,15,19,2
    0,21,22)/t4-,6-,7-,10-/m1
    /s1;
    WUPFAKUEHUVIDK-KQYNXXCUSA-N    		 c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C
    @H](O3)COP(=O)(NP(=O)(O)OP(=O)(O)O)O)O)O
    )N; c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)
    (NP(=O)(O)OP(=O)(O)O)O)O)O)N; Nc1ncnc2n(
    cnc12)[C@@H]3O[C@H](CO[P](O)(=O)N[P](O)(
    =O)O[P](O)(O)=O)[C@@H](O)[C@H]3O; Nc1ncn
    c2n(cnc12)[CH]3O[CH](CO[P](O)(=O)N[P](O)
    (=O)O[P](O)(O)=O)[CH](O)[CH]3O; O=P(O)(O
    )OP(=O)(O)NP(=O)(O)OCC3OC(n2cnc1c(ncnc12
    )N)C(O)C3O    		 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]amino}phosphoryl]adenosine
    639
    ZBA
    ZINC000058649583    		 2 C24 H32 O9 InChI=1S/C24H32O9/c1-12(2
    )7-18(27)32-16-9-23(10-29
    -14(4)25)17(8-13(16)3)33-
    21-19(28)20(31-15(5)26)22
    (23,6)24(21)11-30-24/h8,1
    6-17,19-21,28H,1,7,9-11H2
    ,2-6H3/t16-,17+,19+,20+,2
    1+,22+,23+,24-/m0/s1;
    JESYGVLQSIZOBZ-QYWOHJEZSA-N    		 CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)CC(=C)C)(
    [C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O
    )OC(=O)C)C)COC(=O)C; O=C(OC4C(=CC3OC2C1(
    OC1)C(C(OC(=O)C)C2O)(C)C3(COC(=O)C)C4)C)
    CC(=C)\C; CC(=C)CC(=O)O[C@H]1C[C@@]2(COC
    (C)=O)[C@H](O[C@@H]3[C@H](O)[C@@H](OC(C)
    =O)[C@@]2(C)[C@]34CO4)C=C1C; CC(=C)CC(=O
    )O[CH]1C[C]2(COC(C)=O)[CH](O[CH]3[CH](O)
    [CH](OC(C)=O)[C]2(C)[C]34CO4)C=C1C; CC1=
    CC2C(CC1OC(=O)CC(=C)C)(C3(C(C(C(C34CO4)O
    2)O)OC(=O)C)C)COC(=O)C    		 12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate
    640
    ZC0
    CHEMBL3287379
    DB12796    		 1 C18 H15 F3 N4 O4 InChI=1S/C18H15F3N4O4/c19
    -12-7-13(15(20)16(21)17(1
    2)24-4-1-10(26)2-5-24)25-
    9-11(29-18(25)27)8-22-14-
    3-6-28-23-14/h1,3-4,6-7,1
    1H,2,5,8-9H2,(H,22,23)/t1
    1-/m0/s1;
    SULYVXZZUMRQAX-NSHDSACASA-N    		 c1conc1NC[C@H]2CN(C(=O)O2)c3cc(c(c(c3F)F
    )N4CCC(=O)C=C4)F; c1conc1NCC2CN(C(=O)O2)
    c3cc(c(c(c3F)F)N4CCC(=O)C=C4)F; Fc1cc(N2
    C[CH](CNc3ccon3)OC2=O)c(F)c(F)c1N4CCC(=O
    )C=C4; Fc1cc(N2C[C@H](CNc3ccon3)OC2=O)c(
    F)c(F)c1N4CCC(=O)C=C4; C1C(C=CN(C1)c2c(F
    )cc(c(c2F)F)N3CC(OC3=O)CNc4ccon4)=O    		 Contezolid;
    MRX-I
    641
    ZIT
    CHEMBL529
    DB00207
    ZINC000085537026    		 11 C38 H72 N2 O12 InChI=1S/C38H72N2O12/c1-1
    5-27-38(10,46)31(42)24(6)
    40(13)19-20(2)17-36(8,45)
    33(52-35-29(41)26(39(11)1
    2)16-21(3)48-35)22(4)30(2
    3(5)34(44)50-27)51-28-18-
    37(9,47-14)32(43)25(7)49-
    28/h20-33,35,41-43,45-46H
    ,15-19H2,1-14H3/t20-,21-,
    22+,23-,24-,25+,26+,27-,2
    8+,29-,30+,31-,32+,33-,35
    +,36-,37-,38-/m1/s1;
    MQTOSJVFKKJCRP-BICOPXKESA-N    		 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@
    @](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@
    @H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C
    )C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@
    H](O)[C@]1(C)O; O=C3OC(CC)C(O)(C)C(O)C(N
    (C)CC(C)CC(O)(C)C(OC1OC(C)CC(N(C)C)C1O)C
    (C(OC2OC(C(O)C(OC)(C2)C)C)C3C)C)C; CC[CH
    ]1OC(=O)[CH](C)[CH](O[CH]2C[C](C)(OC)[CH
    ](O)[CH](C)O2)[CH](C)[CH](O[CH]3O[CH](C)
    C[CH]([CH]3O)N(C)C)[C](C)(O)C[CH](C)CN(C
    )[CH](C)[CH](O)[C]1(C)O; CCC1C(C(C(N(CC(
    CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C
    )OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)
    O)(C)O; CC[C@@H]1[C@@]([C@@H]([C@H]([N@@
    ](C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@
    H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](
    O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H
    ](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O    		 AZITHROMYCIN
    642
    ZLD
    CHEMBL126
    DB00601
    ZINC000002008866    		 6 C16 H20 F N3 O4 InChI=1S/C16H20FN3O4/c1-1
    1(21)18-9-13-10-20(16(22)
    24-13)12-2-3-15(14(17)8-1
    2)19-4-6-23-7-5-19/h2-3,8
    ,13H,4-7,9-10H2,1H3,(H,18
    ,21)/t13-/m0/s1;
    TYZROVQLWOKYKF-ZDUSSCGKSA-N    		 CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3
    CCOCC3; CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N
    3CCOCC3)c(F)c2; O=C1OC(CNC(=O)C)CN1c3cc(
    F)c(N2CCOCC2)cc3; CC(=O)NCC1CN(C(=O)O1)c
    2ccc(c(c2)F)N3CCOCC3; CC(=O)NC[CH]1CN(C(
    =O)O1)c2ccc(N3CCOCC3)c(F)c2    		 N-{[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide;
    Linezolid
    643
    ZN
    CHEMBL1236970
    DB14532    		 10 Zn InChI=1S/Zn/q+2;
    PTFCDOFLOPIGGS-UHFFFAOYSA-N    		 [Zn++]; [Zn+2] ZINC ION
    644
    ZVM    		 2 C22 H21 N3 O2 InChI=1S/C22H21N3O2/c1-24
    -17-13-6-5-12-16(17)19(26
    )18-21(24)23-20(14-8-7-9-
    14)25(22(18)27)15-10-3-2-
    4-11-15/h2-6,10-14,18,20H
    ,7-9H2,1H3/t18?,20-/m0/s1;
    HIWASGKNWCATJA-IJHRGXPZSA-N    		 O=C1C2C(=O)c3ccccc3N(C)C2=NC(C2CCC2)N1c1
    ccccc1; CN1c2ccccc2C(=O)C3C1=NC(N(C3=O)c
    4ccccc4)C5CCC5; CN1c2ccccc2C(=O)[CH]3C(=
    O)N([CH](N=C13)C4CCC4)c5ccccc5; CN1c2ccc
    cc2C(=O)[C@H]3C(=O)N([C@H](N=C13)C4CCC4)
    c5ccccc5    		 (2S,4aS)-2-cyclobutyl-10-methyl-3-phenyl-2,10-dihydropyrimido[4,5-b]quinoline-4,5(3H,4aH)-dione
    645
    ZWB    		 2 C20 H30 Br N O4 InChI=1S/C20H30BrNO4/c1-1
    0-13(6-15(24)12-5-17(25)2
    2-18(12)26)20(4)9-11(21)8
    -19(2,3)16(20)7-14(10)23/
    h11-16,23-24H,1,5-9H2,2-4
    H3,(H,22,25,26)/t11-,12+,
    13-,14-,15-,16-,20+/m0/s1;
    KFLGGORBXJSMNM-LWHFJPTFSA-N    		 C[C@]12C[C@H](CC([C@@H]1C[C@@H](C(=C)[C@
    @H]2C[C@@H]([C@H]3CC(=O)NC3=O)O)O)(C)C)B
    r; CC1(C)C[CH](Br)C[C]2(C)[CH](C[CH](O)[
    CH]3CC(=O)NC3=O)C(=C)[CH](O)C[CH]12; CC1
    (C)C[C@H](Br)C[C@]2(C)[C@@H](C[C@H](O)[C
    @H]3CC(=O)NC3=O)C(=C)[C@@H](O)C[C@@H]12;
    CC1(CC(CC2(C1CC(C(=C)C2CC(C3CC(=O)NC3=O
    )O)O)C)Br)C    		 (3~{R})-3-[(1~{S})-2-[(1~{R},3~{S},4~{a}~{S},7~{S},8~{a}~{S})-7-bromanyl-5,5,8~{a}-trimethyl-2-methylidene-3-oxidanyl-3,4,4~{a},6,7,8-hexahydro-1~{H}-naphthalen-1-yl]-1-oxidanyl-ethyl]pyrrolidine-2,5-dione
    646
    ZZR
    ZINC000103563006    		 1 C3 H6 N7 InChI=1S/C3H5N7/c4-1-6-3-
    8-7-2(5)10(3)9-1/h(H5,4,5
    ,6,7,8,9)/p+1;
    JFMHNXXJHXPFLE-UHFFFAOYSA-O    		 Nc1[nH][n+]2c(N)n[nH]c2n1; n1c(N)n[n+]2c
    (nnc12)N; c1([nH][n+]2c(n[nH]c2n1)N)N    		 3,6-diamino-1,5-dihydro[1,2,4]triazolo[4,3-b][1,2,4]triazol-4-ium
    647
    ZZS
    ZINC000001445475    		 1 C3 H5 N5 InChI=1S/C3H5N5/c4-2-6-1-
    7-3(5)8-2/h1H,(H4,4,5,6,7
    ,8);
    VZXTWGWHSMCWGA-UHFFFAOYSA-N    		 n1c(nc(nc1)N)N; c1nc(nc(n1)N)N; Nc1ncnc(
    N)n1    		 1,3,5-TRIAZINE-2,4-DIAMINE
    Reference:
  • Chengxin Zhang, Lydia Freddolino (2024) "FURNA: a database for function annotations of RNA structures," PLOS Biology 22(7): e3002476.